Sanara MedTech posts higher Q4 revenue, reaffirms guidance

Sanara MedTech

24/03/2026 11:08

Overview

U.S. surgical products maker's Q4 revenue rose 5% yr/yr; full-year revenue up 19%

Company posted Q4 net loss from continuing operations versus profit a year ago

Sanara reaffirmed 2026 revenue guidance for 13%-17% growth

Outlook

Sanara reaffirms 2026 net revenue guidance of $116 mln to $121 mln, up 13%-17% year-over-year

Company plans to increase R&D spending in 2026 to support existing products and pipeline

Sanara expects expanded market access and commercial execution to drive long-term growth and profitability

Result Drivers

SOFT TISSUE REPAIR SALES - Increased sales of CellerateRX Surgical drove revenue growth, aided by expanded facility penetration and distributor network

GROSS MARGIN IMPROVEMENT - Higher gross margin in Q4 was primarily due to increased soft tissue repair sales and lower manufacturing costs for CellerateRX Surgical

OPERATING EXPENSES - Q4 operating expenses rose due to asset impairment charge and higher R&D spending tied to product enhancement initiatives

Company press release: ID:nGNX8P8Fyw

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
Slight Beat*
$103.10 mln
$102.55 mln (1 Analyst)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The one available analyst rating on the shares is "buy"

The average consensus recommendation for the pharmaceuticals peer group is "buy"

Wall Street's median 12-month price target for Sanara Medtech Inc is $36.00, about 96.3% above its March 23 closing price of $18.34

The stock recently traded at 28 times the next 12-month earnings vs. a P/E of 18 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)